Literature DB >> 17683928

Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma.

Angélica Morales1, Felipe Vilchis, Bertha Chávez, Carlos Chan, Guillermo Robles-Díaz, Vicente Díaz-Sánchez.   

Abstract

Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) was recently identified as the first tissue-specific angiogenic molecule. EG-VEGF (the gene product of PROK-1) appears to be expressed exclusively in steroid-producing organs such as the ovary, testis, adrenals and placenta. Since the human pancreatic cells retain steroidogenic activity, in the present study we ascertained whether this angiogenic factor is expressed in normal pancreas and pancreatic adenocarcinoma. Tissue samples from normal males (n=5), normal females (n=5) and from surgically resected adenocarcinomas (n=2) were processed for RT-PCR and immunohistochemical studies. Results from semi-quantitative analysis by RT-PCR suggest a distinct expression level for EG-VEGF in the different tissue samples. The relative amount of EG-VEGF mRNA in pancreas was more abundant in female adenocarcinoma (0.89) followed by male adenocarcinoma (0.71), than normal female (0.64) and normal male (0.38). The expression of mRNA for EG-VEGF in normal tissue was significantly higher in females than in males. All samples examined showed specific immunostaining for EG-VEGF. In male preparations, the positive labeling was localized predominantly within the pancreatic islets while in female preparations the main staining was detected towards the exocrine portion. Specific immunolabeling was also observed in endothelial cells of pancreatic blood vessels. Our data provide evidence that the human pancreas expresses the EG-VEGF, a highly specific mitogen which regulates proliferation and differentiation of the vascular endothelium. The significance of this finding could be interpreted as either, EG-VEGF is not exclusive of endocrine organs, or the pancreas should be considered as a functional steroidogenic tissue. The extent of the expression of EG-VEGF appears to have a dimorphic pattern in normal and tumoral pancreatic tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683928     DOI: 10.1016/j.jsbmb.2007.02.006

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer.

Authors:  Takanori Goi; Toshiyuki Nakazawa; Yasuo Hirono; Akio Yamaguchi
Journal:  Oncotarget       Date:  2015-03-20

2.  Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors.

Authors:  Dorothee Heck; Sebastian Wortmann; Luitgard Kraus; Cristina L Ronchi; Richard O Sinnott; Martin Fassnacht; Silviu Sbiera
Journal:  Horm Cancer       Date:  2015-12       Impact factor: 3.869

3.  Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.

Authors:  Takanori Goi; Hidetaka Kurebayashi; Yuki Ueda; Takayuki Naruse; Toshiyuki Nakazawa; Kenji Koneri; Yasuo Hirono; Kanji Katayama; Akio Yamaguchi
Journal:  Oncotarget       Date:  2015-10-13

4.  The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).

Authors:  Takanori Goi; Toshiyuki Nakazawa; Yasuo Hirono; Akio Yamaguchi
Journal:  Oncotarget       Date:  2015-10-06

Review 5.  Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis.

Authors:  Ana Silvia Corlan; Anca Maria Cîmpean; Adriana-Andreea Jitariu; Eugen Melnic; Marius Raica
Journal:  Int J Endocrinol       Date:  2017-03-12       Impact factor: 3.257

6.  VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas.

Authors:  Ana Silvia Corlan; Anca Maria Cîmpean; Eugen Melnic; Marius Raica; Simona Sarb
Journal:  Eur J Histochem       Date:  2019-03-05       Impact factor: 3.188

7.  Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma.

Authors:  S Lauttia; H Sihto; H Kavola; V Koljonen; T Böhling; H Joensuu
Journal:  Br J Cancer       Date:  2014-02-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.